162 related articles for article (PubMed ID: 29430546)
1. Characterization of patients with ocular myasthenia gravis - A case series.
Karni A; Asmail A; Drory VE; Kolb H; Kesler A
eNeurologicalSci; 2016 Sep; 4():30-33. PubMed ID: 29430546
[TBL] [Abstract][Full Text] [Related]
2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
3. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
Guan YZ; Cui LY; Liu MS; Niu JW
Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
[TBL] [Abstract][Full Text] [Related]
4. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
5. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
[TBL] [Abstract][Full Text] [Related]
6. Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma.
Supawongwattana M; Vanikieti K; Jindahra P; Padungkiatsagul T
Clin Ophthalmol; 2023; 17():649-656. PubMed ID: 36875532
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.
Hendricks TM; Bhatti MT; Hodge DO; Chen JJ
Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669
[TBL] [Abstract][Full Text] [Related]
8. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis.
Zhang J; Zhang Z; Zhang H; Cui Y; Chen Y; Lv P; Zhang P
Orphanet J Rare Dis; 2022 Aug; 17(1):309. PubMed ID: 35945595
[TBL] [Abstract][Full Text] [Related]
9. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
[TBL] [Abstract][Full Text] [Related]
10. Antibody profile may predict outcome in ocular myasthenia gravis.
Galassi G; Mazzoli M; Ariatti A; Kaleci S; Valzania F; Nichelli PF
Acta Neurol Belg; 2018 Sep; 118(3):435-443. PubMed ID: 29858757
[TBL] [Abstract][Full Text] [Related]
11. Ocular Myasthenia: Clinical Course and the Diagnostic Utility of Assaying Acetylcholine Receptor Antibodies.
Behbehani R; Ali A; Al-Moosa A
Neuroophthalmology; 2022; 46(4):220-226. PubMed ID: 35859633
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
[TBL] [Abstract][Full Text] [Related]
13. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
14. Ocular myasthenia gravis: predictive value of single-fiber electromyography.
Weinberg DH; Rizzo JF; Hayes MT; Kneeland MD; Kelly JJ
Muscle Nerve; 1999 Sep; 22(9):1222-7. PubMed ID: 10454717
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
Aguirre F; Villa AM
Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
[TBL] [Abstract][Full Text] [Related]
16. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
17. Prognostic predictors of remission in ocular myasthenia gravis.
Çelebisoy N; Orujov A; Balayeva F; Özdemir HN; Ak AK; Gökçay F
Acta Neurol Belg; 2023 Oct; 123(5):1927-1932. PubMed ID: 36474006
[TBL] [Abstract][Full Text] [Related]
18. The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review.
Wilson L; Davis H
Br Ir Orthopt J; 2023; 19(1):108-119. PubMed ID: 38046270
[TBL] [Abstract][Full Text] [Related]
19. Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis.
Zhang M; Guo J; Li H; Zhou Y; Tian F; Gong L; Wang X; Li Z; Zhang W
J Mol Neurosci; 2013 Jun; 50(2):317-23. PubMed ID: 23397576
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
Monte G; Spagni G; Damato V; Iorio R; Marino M; Evoli A
J Neurol; 2021 May; 268(5):1803-1807. PubMed ID: 33387011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
